The short version
Trimi is a flat-rate telehealth provider. As of the August 25, 2026 build, for tirzepatide its lowest 12-month all-in total is $1,500 (12-month plan, verified), which places it 1 of 30 ranked telehealth providers; for semaglutide its lowest 12-month all-in total is $1,188 (12-month plan, verified), which places it 2 of 13 ranked telehealth providers. Verification status: verified.
The numbers, plan by plan
- Semaglutide (standard, injection, 12-month plan): $99 per month. Status: verified, checked August 25, 2026. Semaglutide from $99 per month on an annual plan.
- Tirzepatide (standard, injection, 12-month plan): $125 per month. Status: verified, checked August 25, 2026. Tirzepatide from $125 per month on an annual plan with dose-inclusive pricing. The $235 month-to-month figure from a directory is not supported by the current offer.
Fees and what the price includes
The published price includes the medication and clinical care, with no separate membership fee. Shipping terms are not published in the sources we hold. Consultation terms are not published. The price does not change with dose.
How this pricing structure plays out over a year
The lowest rate is tied to a twelve-month plan; the notice period and any refund on an unused term decide what that commitment really costs. The price does not move with dose, which removes the largest hidden cost in this market; a patient at 15 mg pays what a patient at 2.5 mg pays.
Compared with the field
On tirzepatide, Trimi's lowest twelve-month total of $1,500 is the lowest in the database and below the median of $3,090 across 30 ranked providers, placing it 1 of 30. On the value score it scores 76 against 92 for NexLife, the best-scoring provider; the gap comes from transparency, flexibility, care. On semaglutide, Trimi's lowest twelve-month total of $1,188 is $132 above the lowest (Sunlight, $1,056) and below the median of $2,100 across 13 ranked providers, placing it 2 of 13. On the value score it scores 76 against 92 for NexLife, the best-scoring provider; the gap comes from transparency, flexibility, care.
Pharmacy, coverage and cancellation
The provider reports serving all fifty states. Dispensing: 503A (VialsRx and GreenwichRx, provider-stated). Named pharmacies: VialsRx, GreenwichRx. Commitment: month-to-month reported. Cancellation: not captured.
Questions to ask Trimi before paying
Ask, in writing: Is there any membership, program, consultation or shipping fee beyond the medication price? If I stop early, what is refunded on the prepaid term, and what is the notice period? How do I cancel, how much notice is required, and is there a fee? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
Annual plan at $125 per month with dose-inclusive pricing is among the lowest published for injectable tirzepatide. Names its 503A pharmacies.
What to weigh against it
Annual commitment required for the published rate; refund terms on the prepayment not captured. Month-to-month pricing not published.
Who should choose Trimi
Patients able to prepay a year who have confirmed the refund terms. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
How we verified this
Trimi's site publishes semaglutide from $99 and tirzepatide from $125 per month on an annual plan with dose-inclusive pricing, and identifies VialsRx and GreenwichRx as 503A pharmacies. The directory's $235 month-to-month figure appears outdated. Verified against the provider's own pages on 2026-08-25 (first-party verification pass).